SOGC’s expert Dr. Darine El-Chaar talks to CBC about health care providers having to manage the fallout of using Tylenol while pregnant with patients after the U.S. government’s announcement suggesting Tylenol during pregnancy can contribute to autism. The article featured the SOGC’s recent position statement reaffirming the safety of acetaminophen use during pregnancy.
The SOGC emphasizes that acetaminophen remains a safe and appropriate option for managing fever and pain during pregnancy when used at the lowest effective dose for the shortest necessary time. The SOGC revisited the scientific evidence amid reports of shifting medical advice in the U.S. and reasserted that current evidence does not establish a causal connection between acetaminophen and autism.
Read the full CBC story here: https://ici.radio-canada.ca/rci/en/news/2194788/trumps-autism-announcement-leaves-tylenols-parent-company-with-pr-crisis
For more information, please refer to the full SOGC Position Statement on the use of Acetaminophen for Analgesia and Fever in Pregnancy: https://sogc.org/common/Uploaded%20files/Position%20Statements/SOGC%20Position%20Statement%20Acetamenophin_EN_20250911.pdf